Primary Stability of the ImplantsNCT03661658
Inferior Alveolar Nerve Lateralization With Simultaneous Implant Placement Versus the Use of Short Dental Implants
A study testing Using short dental implant and Inferior alveolar nerve lateralization with simultaneous implant placement in people with Primary Stability of the Implants and Marginal Bone Loss, run by Cairo University at 1 site in Egypt.
Trial summary
Assess the long term stability of short dental implants in comparison to standard implants inserted simultaneously with inferior alveolar nerve lateralization. Read more about this study
- Who is it for?
- Ages 20 to 55 yearsHealthy volunteers can take part
- Conditions the study is for
- Primary Stability of the Implants, Marginal Bone Loss
- What is being tested?
- Using short dental implant and Inferior alveolar nerve lateralization with simultaneous implant placement
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 8 participants
- Where
- 1 siteEgypt
- Study dates
- Sep 2018to Jun 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 55 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Adult patients with edentulous posterior mandible.
- Both sexes.
- No intraoral soft and hard tissue pathology.
- No systemic condition that contraindicate implant placement.
- Residual alveolar bone width longer than 6 mm height (7-9 mm).
Who cannot join
- Presence of fenestrations or dehiscence of the residual ridge.
- Heavy smokers more than 20 cigarettes per day .(24)
- Patients with systemic disease that may affect normal healing.
- Psychiatric problems
- Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site.
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Ehab Ahmed Shams
Cairo
Ehab Ahmed Shams, PDS, 00201005233925, ehab_ahmed_206@hotmail.com
About this study
Assess the long term stability of short dental implants in comparison to standard implants inserted simultaneously with inferior alveolar nerve lateralization.
- Being tested
- Using short dental implant, Inferior alveolar nerve lateralization with simultaneous implant placement
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Using short dental implantProcedure or surgery
Using short dental implant for patients with atrophic posterior mandible.
Inferior alveolar nerve lateralization with simultaneous implant placementProcedure or surgery
Inferior alveolar nerve lateralization with simultaneous implant placement in atrophic posterior mandible.
| Study group | Role | What they receive |
|---|---|---|
| Inferior alveolar nerve lateralization with implant placement | Active comparator | Not described Receives: Procedure: Inferior alveolar nerve lateralization with simultaneous implant placement |
| Using short dental implant with atrophic mandible | Experimental | Not described Receives: Procedure: Using short dental implant |
What is being measured
The primary outcome is the main question the study is designed to answer.
Primary stability
measuring the primary stability using the osstel
Measured: 3 months
Secondary outcomes (1)
Marginal bone loss
measuring the marginal bone loss by using CBCT
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Sep 2018
- Study startSep 2018 (estimated)
- Primary completionFeb 2019 (estimated)
- Study completionJun 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Primary Stability of the ImplantsStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 8 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ehab Ahmed Shams, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03661658
- Sponsor's protocol ID
- cairo university 8
- Status last verified
- Sep 2018
- First submitted
- 2 Sep 2018
- Last updated
- 7 Sep 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 7 Sep 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Inferior Alveolar Nerve Lateralization With Simultaneous Implant Placement Versus the Use of Short Dental Implants
- ClinicalTrials.gov ID
- NCT03661658
- Acronym / sponsor ID
- cairo university 8
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 8 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- Sep 2018 (estimated)
- Primary completion
- Feb 2019 (estimated)
- Study completion
- Jun 2019 (estimated)
- First posted
- 7 Sep 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Assess the long term stability of short dental implants in comparison to standard implants inserted simultaneously with inferior alveolar nerve lateralization.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Inferior alveolar nerve lateralization with implant placement | Active comparator | Procedure: Inferior alveolar nerve lateralization with simultaneous implant placement |
| Using short dental implant with atrophic mandible | Experimental | Procedure: Using short dental implant |
Who may qualify
- Ages
- 20 to 55 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Adult patients with edentulous posterior mandible.
- Both sexes.
- No intraoral soft and hard tissue pathology.
- No systemic condition that contraindicate implant placement.
- Residual alveolar bone width longer than 6 mm height (7-9 mm).
Key exclusion criteria (5 listed)
- Presence of fenestrations or dehiscence of the residual ridge.
- Heavy smokers more than 20 cigarettes per day .(24)
- Patients with systemic disease that may affect normal healing.
- Psychiatric problems
- Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Using short dental implantUsing short dental implant for patients with atrophic posterior mandible. | Procedure or surgery | Using short dental implant with atrophic mandible |
| Inferior alveolar nerve lateralization with simultaneous implant placementInferior alveolar nerve lateralization with simultaneous implant placement in atrophic posterior mandible. | Procedure or surgery | Inferior alveolar nerve lateralization with implant placement |
Primary outcome
Primary stability
Time frame: 3 months
measuring the primary stability using the osstel
1 secondary outcome
Marginal bone loss
Time frame: 3 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Sep 2018.
- Individual participant dataSharing planned: Yes
Related trials for Primary Stability of the Implants
Not yet recruiting
Comparative Assessment of Primary Stability in Double, and Triple Thread Implant Designs
Dental Implant, Primary Stability of the Implants
Not yet recruiting
Influence of Alveolar Bone Drilling and Anatomical Position on Integration
Dental Implant, Bone Grafting
Not yet recruiting
Influence of the Primary Stability and Temporary Prosthetics
Immediate Dental Implant Placement, Immediate Dental Implant Loading
Not yet recruiting
Thymoquinone Around Immediate Implant
Immediate Dental Implant Placement, Jumping Gap
Not yet recruiting
Evaluation of the Effect of Different Thread Designs on Primary Stability of Dental Implant Using Osseodensification Technique in Posterior Maxilla : Randomized Clinical Trial
Primary Stability of Knife Threads Dental Implant Versus Double Threads Using Osseodensification Technique
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Using short dental implant and Inferior alveolar nerve lateralization with simultaneous implant placement in people with Primary Stability of the Implants and Marginal Bone Loss, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 7 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Primary stability (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Sep 2018.